Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain

► Environmental correlates for essential tremor (ET) are largely unexplored. ► Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. ► Blood harmane levels were quantified by high performance liquid chromatography. ► Blood harmane levels were elevated in familial ET cases vs....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurotoxicology (Park Forest South) 2013-01, Vol.34, p.264-268
Hauptverfasser: Louis, Elan D., Benito-León, Julian, Moreno-García, Sara, Vega, Saturio, Romero, Juan Pablo, Bermejo-Pareja, Felix, Gerbin, Marina, Viner, Amanda S., Factor-Litvak, Pam, Jiang, Wendy, Zheng, Wei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 268
container_issue
container_start_page 264
container_title Neurotoxicology (Park Forest South)
container_volume 34
creator Louis, Elan D.
Benito-León, Julian
Moreno-García, Sara
Vega, Saturio
Romero, Juan Pablo
Bermejo-Pareja, Felix
Gerbin, Marina
Viner, Amanda S.
Factor-Litvak, Pam
Jiang, Wendy
Zheng, Wei
description ► Environmental correlates for essential tremor (ET) are largely unexplored. ► Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. ► Blood harmane levels were quantified by high performance liquid chromatography. ► Blood harmane levels were elevated in familial ET cases vs. controls in Spain. ► These data extend observations from New York to a second cohort of cases in Spain. Environmental correlates for essential tremor (ET) are largely unexplored. The search for such environmental factors has involved the study of a number of neurotoxins. Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. In two prior case–control studies in New York, we demonstrated that blood harmane concentration was elevated in ET patients vs. controls, and especially in familial ET cases. These findings, however, have been derived from a study of cases ascertained through a single tertiary referral center in New York. Our objective was to determine whether blood harmane concentrations are elevated in familial and sporadic ET cases, ascertained from central Spain, compared to controls without ET. Blood harmane concentrations were quantified by a well-established high performance liquid chromatography method. The median harmane concentrations were: 2.09g−10/ml (138 controls), 2.41g−10/ml (68 sporadic ET), and 2.90g−10/ml (62 familial ET). In an unadjusted logistic regression analysis, log blood harmane concentration was not significantly associated with diagnosis (familial ET vs. control): odds ratio=1.56, p=0.26. In a logistic regression analysis that adjusted for evaluation start time, which was an important confounding variable, the odds ratio increased to 2.35, p=0.049. Blood harmane levels were slightly elevated in a group of familial ET cases compared to a group of controls in Spain. These data seem to further extend our observations from New York to a second cohort of ET cases in Spain. This neurotoxin continues to be a source of interest for future confirmatory research.
doi_str_mv 10.1016/j.neuro.2012.09.004
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3556362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161813X12002161</els_id><sourcerecordid>1664192512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c522t-764f6bbd72b6c0fbfd1d36aac0e681e1a49cfeed1d60b4ad4694204a1b1ce1493</originalsourceid><addsrcrecordid>eNp9kdFrFDEQxoMo9lr9CwTZF6GCu2ay2ezmwUIt1QoFH1QQRGI2mfVy7CZnsle4_74576z1xacwmd988zEfIc-AVkBBvF5VHjcxVIwCq6isKOUPyAK6lpWyBXhIFpmCsoP66xE5TmlFKTStkI_JEWOyA9myBfnxdgzBFksdJ-2xOIVywnm5HUt5Va630dnwrX7Fy_678zaM-LIwwRv0c9SzC75wvsCUcu30WMwRpxALoxOmXefTWjv_hDwa9Jjw6eE9IV_eXX6-uCqvP77_cHF-XZqGsblsBR9E39uW9cLQoR8s2FpobSiKDhA0l2ZAzL-C9lxbLiRnlGvowSBwWZ-Qs73uetNPaPceR7WObtJxq4J26t-Od0v1M9youmlELVgWOD0IxPBrg2lWk0sGxzHfJWySAiE4SNbADq33qIkhpYjD3RqgapeNWqnf2ahdNopKlbPJU8_vO7yb-RNGBl4cAJ2MHoeovXHpLyfyds67zL3Zc5jveeMwqmQc5lisi2hmZYP7r5Fb49ewBQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664192512</pqid></control><display><type>article</type><title>Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Louis, Elan D. ; Benito-León, Julian ; Moreno-García, Sara ; Vega, Saturio ; Romero, Juan Pablo ; Bermejo-Pareja, Felix ; Gerbin, Marina ; Viner, Amanda S. ; Factor-Litvak, Pam ; Jiang, Wendy ; Zheng, Wei</creator><creatorcontrib>Louis, Elan D. ; Benito-León, Julian ; Moreno-García, Sara ; Vega, Saturio ; Romero, Juan Pablo ; Bermejo-Pareja, Felix ; Gerbin, Marina ; Viner, Amanda S. ; Factor-Litvak, Pam ; Jiang, Wendy ; Zheng, Wei</creatorcontrib><description>► Environmental correlates for essential tremor (ET) are largely unexplored. ► Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. ► Blood harmane levels were quantified by high performance liquid chromatography. ► Blood harmane levels were elevated in familial ET cases vs. controls in Spain. ► These data extend observations from New York to a second cohort of cases in Spain. Environmental correlates for essential tremor (ET) are largely unexplored. The search for such environmental factors has involved the study of a number of neurotoxins. Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. In two prior case–control studies in New York, we demonstrated that blood harmane concentration was elevated in ET patients vs. controls, and especially in familial ET cases. These findings, however, have been derived from a study of cases ascertained through a single tertiary referral center in New York. Our objective was to determine whether blood harmane concentrations are elevated in familial and sporadic ET cases, ascertained from central Spain, compared to controls without ET. Blood harmane concentrations were quantified by a well-established high performance liquid chromatography method. The median harmane concentrations were: 2.09g−10/ml (138 controls), 2.41g−10/ml (68 sporadic ET), and 2.90g−10/ml (62 familial ET). In an unadjusted logistic regression analysis, log blood harmane concentration was not significantly associated with diagnosis (familial ET vs. control): odds ratio=1.56, p=0.26. In a logistic regression analysis that adjusted for evaluation start time, which was an important confounding variable, the odds ratio increased to 2.35, p=0.049. Blood harmane levels were slightly elevated in a group of familial ET cases compared to a group of controls in Spain. These data seem to further extend our observations from New York to a second cohort of ET cases in Spain. This neurotoxin continues to be a source of interest for future confirmatory research.</description><identifier>ISSN: 0161-813X</identifier><identifier>EISSN: 1872-9711</identifier><identifier>DOI: 10.1016/j.neuro.2012.09.004</identifier><identifier>PMID: 22981972</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Aged ; Aged, 80 and over ; Air. Soil. Water. Waste. Feeding ; Analysis of Variance ; Biological and medical sciences ; Case-Control Studies ; Chi-Square Distribution ; Chromatography, High Pressure Liquid ; Environment. Living conditions ; Environmental Pollutants - adverse effects ; Environmental Pollutants - blood ; Environmental risk factors ; Epidemiology ; Essential tremor ; Essential Tremor - blood ; Essential Tremor - chemically induced ; Essential Tremor - epidemiology ; Essential Tremor - physiopathology ; Female ; Harmane ; Harmine - adverse effects ; Harmine - analogs &amp; derivatives ; Harmine - blood ; Humans ; Logistic Models ; Longitudinal Studies ; Male ; Medical sciences ; Middle Aged ; Nervous system (semeiology, syndromes) ; Nervous system as a whole ; Neurology ; Neurotoxicity Syndromes - blood ; Neurotoxicity Syndromes - epidemiology ; Neurotoxicity Syndromes - physiopathology ; Odds Ratio ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Risk Assessment ; Risk Factors ; Spain - epidemiology ; Toxicology ; Toxin ; Up-Regulation ; β-Carboline alkaloid</subject><ispartof>Neurotoxicology (Park Forest South), 2013-01, Vol.34, p.264-268</ispartof><rights>2012 Elsevier Inc.</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><rights>2012 Elsevier B.V. All rights reserved. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c522t-764f6bbd72b6c0fbfd1d36aac0e681e1a49cfeed1d60b4ad4694204a1b1ce1493</citedby><cites>FETCH-LOGICAL-c522t-764f6bbd72b6c0fbfd1d36aac0e681e1a49cfeed1d60b4ad4694204a1b1ce1493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuro.2012.09.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26925448$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22981972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Louis, Elan D.</creatorcontrib><creatorcontrib>Benito-León, Julian</creatorcontrib><creatorcontrib>Moreno-García, Sara</creatorcontrib><creatorcontrib>Vega, Saturio</creatorcontrib><creatorcontrib>Romero, Juan Pablo</creatorcontrib><creatorcontrib>Bermejo-Pareja, Felix</creatorcontrib><creatorcontrib>Gerbin, Marina</creatorcontrib><creatorcontrib>Viner, Amanda S.</creatorcontrib><creatorcontrib>Factor-Litvak, Pam</creatorcontrib><creatorcontrib>Jiang, Wendy</creatorcontrib><creatorcontrib>Zheng, Wei</creatorcontrib><title>Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain</title><title>Neurotoxicology (Park Forest South)</title><addtitle>Neurotoxicology</addtitle><description>► Environmental correlates for essential tremor (ET) are largely unexplored. ► Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. ► Blood harmane levels were quantified by high performance liquid chromatography. ► Blood harmane levels were elevated in familial ET cases vs. controls in Spain. ► These data extend observations from New York to a second cohort of cases in Spain. Environmental correlates for essential tremor (ET) are largely unexplored. The search for such environmental factors has involved the study of a number of neurotoxins. Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. In two prior case–control studies in New York, we demonstrated that blood harmane concentration was elevated in ET patients vs. controls, and especially in familial ET cases. These findings, however, have been derived from a study of cases ascertained through a single tertiary referral center in New York. Our objective was to determine whether blood harmane concentrations are elevated in familial and sporadic ET cases, ascertained from central Spain, compared to controls without ET. Blood harmane concentrations were quantified by a well-established high performance liquid chromatography method. The median harmane concentrations were: 2.09g−10/ml (138 controls), 2.41g−10/ml (68 sporadic ET), and 2.90g−10/ml (62 familial ET). In an unadjusted logistic regression analysis, log blood harmane concentration was not significantly associated with diagnosis (familial ET vs. control): odds ratio=1.56, p=0.26. In a logistic regression analysis that adjusted for evaluation start time, which was an important confounding variable, the odds ratio increased to 2.35, p=0.049. Blood harmane levels were slightly elevated in a group of familial ET cases compared to a group of controls in Spain. These data seem to further extend our observations from New York to a second cohort of ET cases in Spain. This neurotoxin continues to be a source of interest for future confirmatory research.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Air. Soil. Water. Waste. Feeding</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Chi-Square Distribution</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Environment. Living conditions</subject><subject>Environmental Pollutants - adverse effects</subject><subject>Environmental Pollutants - blood</subject><subject>Environmental risk factors</subject><subject>Epidemiology</subject><subject>Essential tremor</subject><subject>Essential Tremor - blood</subject><subject>Essential Tremor - chemically induced</subject><subject>Essential Tremor - epidemiology</subject><subject>Essential Tremor - physiopathology</subject><subject>Female</subject><subject>Harmane</subject><subject>Harmine - adverse effects</subject><subject>Harmine - analogs &amp; derivatives</subject><subject>Harmine - blood</subject><subject>Humans</subject><subject>Logistic Models</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Nervous system as a whole</subject><subject>Neurology</subject><subject>Neurotoxicity Syndromes - blood</subject><subject>Neurotoxicity Syndromes - epidemiology</subject><subject>Neurotoxicity Syndromes - physiopathology</subject><subject>Odds Ratio</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Spain - epidemiology</subject><subject>Toxicology</subject><subject>Toxin</subject><subject>Up-Regulation</subject><subject>β-Carboline alkaloid</subject><issn>0161-813X</issn><issn>1872-9711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kdFrFDEQxoMo9lr9CwTZF6GCu2ay2ezmwUIt1QoFH1QQRGI2mfVy7CZnsle4_74576z1xacwmd988zEfIc-AVkBBvF5VHjcxVIwCq6isKOUPyAK6lpWyBXhIFpmCsoP66xE5TmlFKTStkI_JEWOyA9myBfnxdgzBFksdJ-2xOIVywnm5HUt5Va630dnwrX7Fy_678zaM-LIwwRv0c9SzC75wvsCUcu30WMwRpxALoxOmXefTWjv_hDwa9Jjw6eE9IV_eXX6-uCqvP77_cHF-XZqGsblsBR9E39uW9cLQoR8s2FpobSiKDhA0l2ZAzL-C9lxbLiRnlGvowSBwWZ-Qs73uetNPaPceR7WObtJxq4J26t-Od0v1M9youmlELVgWOD0IxPBrg2lWk0sGxzHfJWySAiE4SNbADq33qIkhpYjD3RqgapeNWqnf2ahdNopKlbPJU8_vO7yb-RNGBl4cAJ2MHoeovXHpLyfyds67zL3Zc5jveeMwqmQc5lisi2hmZYP7r5Fb49ewBQ</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Louis, Elan D.</creator><creator>Benito-León, Julian</creator><creator>Moreno-García, Sara</creator><creator>Vega, Saturio</creator><creator>Romero, Juan Pablo</creator><creator>Bermejo-Pareja, Felix</creator><creator>Gerbin, Marina</creator><creator>Viner, Amanda S.</creator><creator>Factor-Litvak, Pam</creator><creator>Jiang, Wendy</creator><creator>Zheng, Wei</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7ST</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>SOI</scope><scope>5PM</scope></search><sort><creationdate>20130101</creationdate><title>Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain</title><author>Louis, Elan D. ; Benito-León, Julian ; Moreno-García, Sara ; Vega, Saturio ; Romero, Juan Pablo ; Bermejo-Pareja, Felix ; Gerbin, Marina ; Viner, Amanda S. ; Factor-Litvak, Pam ; Jiang, Wendy ; Zheng, Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c522t-764f6bbd72b6c0fbfd1d36aac0e681e1a49cfeed1d60b4ad4694204a1b1ce1493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Air. Soil. Water. Waste. Feeding</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Chi-Square Distribution</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Environment. Living conditions</topic><topic>Environmental Pollutants - adverse effects</topic><topic>Environmental Pollutants - blood</topic><topic>Environmental risk factors</topic><topic>Epidemiology</topic><topic>Essential tremor</topic><topic>Essential Tremor - blood</topic><topic>Essential Tremor - chemically induced</topic><topic>Essential Tremor - epidemiology</topic><topic>Essential Tremor - physiopathology</topic><topic>Female</topic><topic>Harmane</topic><topic>Harmine - adverse effects</topic><topic>Harmine - analogs &amp; derivatives</topic><topic>Harmine - blood</topic><topic>Humans</topic><topic>Logistic Models</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Nervous system as a whole</topic><topic>Neurology</topic><topic>Neurotoxicity Syndromes - blood</topic><topic>Neurotoxicity Syndromes - epidemiology</topic><topic>Neurotoxicity Syndromes - physiopathology</topic><topic>Odds Ratio</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Spain - epidemiology</topic><topic>Toxicology</topic><topic>Toxin</topic><topic>Up-Regulation</topic><topic>β-Carboline alkaloid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Louis, Elan D.</creatorcontrib><creatorcontrib>Benito-León, Julian</creatorcontrib><creatorcontrib>Moreno-García, Sara</creatorcontrib><creatorcontrib>Vega, Saturio</creatorcontrib><creatorcontrib>Romero, Juan Pablo</creatorcontrib><creatorcontrib>Bermejo-Pareja, Felix</creatorcontrib><creatorcontrib>Gerbin, Marina</creatorcontrib><creatorcontrib>Viner, Amanda S.</creatorcontrib><creatorcontrib>Factor-Litvak, Pam</creatorcontrib><creatorcontrib>Jiang, Wendy</creatorcontrib><creatorcontrib>Zheng, Wei</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environment Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Environment Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neurotoxicology (Park Forest South)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Louis, Elan D.</au><au>Benito-León, Julian</au><au>Moreno-García, Sara</au><au>Vega, Saturio</au><au>Romero, Juan Pablo</au><au>Bermejo-Pareja, Felix</au><au>Gerbin, Marina</au><au>Viner, Amanda S.</au><au>Factor-Litvak, Pam</au><au>Jiang, Wendy</au><au>Zheng, Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain</atitle><jtitle>Neurotoxicology (Park Forest South)</jtitle><addtitle>Neurotoxicology</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>34</volume><spage>264</spage><epage>268</epage><pages>264-268</pages><issn>0161-813X</issn><eissn>1872-9711</eissn><abstract>► Environmental correlates for essential tremor (ET) are largely unexplored. ► Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. ► Blood harmane levels were quantified by high performance liquid chromatography. ► Blood harmane levels were elevated in familial ET cases vs. controls in Spain. ► These data extend observations from New York to a second cohort of cases in Spain. Environmental correlates for essential tremor (ET) are largely unexplored. The search for such environmental factors has involved the study of a number of neurotoxins. Harmane (1-methyl-9H-pyrido[3,4-b]indole) is a potent tremor-producing toxin. In two prior case–control studies in New York, we demonstrated that blood harmane concentration was elevated in ET patients vs. controls, and especially in familial ET cases. These findings, however, have been derived from a study of cases ascertained through a single tertiary referral center in New York. Our objective was to determine whether blood harmane concentrations are elevated in familial and sporadic ET cases, ascertained from central Spain, compared to controls without ET. Blood harmane concentrations were quantified by a well-established high performance liquid chromatography method. The median harmane concentrations were: 2.09g−10/ml (138 controls), 2.41g−10/ml (68 sporadic ET), and 2.90g−10/ml (62 familial ET). In an unadjusted logistic regression analysis, log blood harmane concentration was not significantly associated with diagnosis (familial ET vs. control): odds ratio=1.56, p=0.26. In a logistic regression analysis that adjusted for evaluation start time, which was an important confounding variable, the odds ratio increased to 2.35, p=0.049. Blood harmane levels were slightly elevated in a group of familial ET cases compared to a group of controls in Spain. These data seem to further extend our observations from New York to a second cohort of ET cases in Spain. This neurotoxin continues to be a source of interest for future confirmatory research.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>22981972</pmid><doi>10.1016/j.neuro.2012.09.004</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0161-813X
ispartof Neurotoxicology (Park Forest South), 2013-01, Vol.34, p.264-268
issn 0161-813X
1872-9711
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3556362
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Aged
Aged, 80 and over
Air. Soil. Water. Waste. Feeding
Analysis of Variance
Biological and medical sciences
Case-Control Studies
Chi-Square Distribution
Chromatography, High Pressure Liquid
Environment. Living conditions
Environmental Pollutants - adverse effects
Environmental Pollutants - blood
Environmental risk factors
Epidemiology
Essential tremor
Essential Tremor - blood
Essential Tremor - chemically induced
Essential Tremor - epidemiology
Essential Tremor - physiopathology
Female
Harmane
Harmine - adverse effects
Harmine - analogs & derivatives
Harmine - blood
Humans
Logistic Models
Longitudinal Studies
Male
Medical sciences
Middle Aged
Nervous system (semeiology, syndromes)
Nervous system as a whole
Neurology
Neurotoxicity Syndromes - blood
Neurotoxicity Syndromes - epidemiology
Neurotoxicity Syndromes - physiopathology
Odds Ratio
Public health. Hygiene
Public health. Hygiene-occupational medicine
Risk Assessment
Risk Factors
Spain - epidemiology
Toxicology
Toxin
Up-Regulation
β-Carboline alkaloid
title Blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentration in essential tremor cases in Spain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A04%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood%20harmane%20(1-methyl-9H-pyrido%5B3,4-b%5Dindole)%20concentration%20in%20essential%20tremor%20cases%20in%20Spain&rft.jtitle=Neurotoxicology%20(Park%20Forest%20South)&rft.au=Louis,%20Elan%20D.&rft.date=2013-01-01&rft.volume=34&rft.spage=264&rft.epage=268&rft.pages=264-268&rft.issn=0161-813X&rft.eissn=1872-9711&rft_id=info:doi/10.1016/j.neuro.2012.09.004&rft_dat=%3Cproquest_pubme%3E1664192512%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1664192512&rft_id=info:pmid/22981972&rft_els_id=S0161813X12002161&rfr_iscdi=true